Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BISNYSEARCA:HYLGNYSEARCA:KMEDNYSEARCA:RXD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBISProShares UltraShort Nasdaq Biotechnology$19.06+2.9%$18.55$14.05▼$25.87$3.24M-1.4111,076 shs4,460 shsHYLGGlobal X Health Care Covered Call & Growth ETF$24.54$24.54$23.50▼$26.65$2.70M0.42499 shsN/AKMEDKraneShares Emerging Markets Healthcare Index ETF$18.81$18.81$18.50▼$23.64$1.88M0.582,085 shsN/ARXDProShares UltraShort Health Care$11.69-0.8%$11.11$9.11▼$13.40$2.23M-1.399,198 shs2,272 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBISProShares UltraShort Nasdaq Biotechnology-3.59%-10.69%+6.62%+10.30%-7.81%HYLGGlobal X Health Care Covered Call & Growth ETF0.00%0.00%0.00%+0.62%-0.99%KMEDKraneShares Emerging Markets Healthcare Index ETF0.00%0.00%0.00%0.00%0.00%RXDProShares UltraShort Health Care-2.40%-2.96%+9.47%+8.56%+4.41%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBISProShares UltraShort Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/AHYLGGlobal X Health Care Covered Call & Growth ETFN/AN/AN/AN/AN/AN/AN/AN/AKMEDKraneShares Emerging Markets Healthcare Index ETFN/AN/AN/AN/AN/AN/AN/AN/ARXDProShares UltraShort Health CareN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBISProShares UltraShort Nasdaq Biotechnology 0.00N/AN/AN/AHYLGGlobal X Health Care Covered Call & Growth ETF 0.00N/AN/AN/AKMEDKraneShares Emerging Markets Healthcare Index ETF 2.92Moderate Buy$18.81N/ARXDProShares UltraShort Health Care 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBISProShares UltraShort Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AHYLGGlobal X Health Care Covered Call & Growth ETFN/AN/AN/AN/AN/AN/AKMEDKraneShares Emerging Markets Healthcare Index ETFN/AN/AN/AN/AN/AN/ARXDProShares UltraShort Health CareN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBISProShares UltraShort Nasdaq BiotechnologyN/AN/A0.00∞N/AN/AN/AN/AN/AHYLGGlobal X Health Care Covered Call & Growth ETFN/AN/A31.64∞N/AN/AN/AN/AN/AKMEDKraneShares Emerging Markets Healthcare Index ETFN/AN/A29.14∞N/AN/AN/AN/AN/ARXDProShares UltraShort Health CareN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBISProShares UltraShort Nasdaq Biotechnology$0.653.41%N/AN/AN/AHYLGGlobal X Health Care Covered Call & Growth ETF$1.265.13%N/AN/AN/AKMEDKraneShares Emerging Markets Healthcare Index ETF$0.050.27%N/AN/AN/ARXDProShares UltraShort Health Care$0.463.93%N/AN/AN/ALatest RXD, KMED, BIS, and HYLG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/25/2025BISProShares UltraShort Nasdaq BiotechnologyQuarterly$0.13252.99%3/26/20253/26/20254/1/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBISProShares UltraShort Nasdaq BiotechnologyN/AHYLGGlobal X Health Care Covered Call & Growth ETFN/AKMEDKraneShares Emerging Markets Healthcare Index ETFN/ARXDProShares UltraShort Health CareN/AInsider OwnershipCompanyInsider OwnershipBISProShares UltraShort Nasdaq BiotechnologyN/AHYLGGlobal X Health Care Covered Call & Growth ETFN/AKMEDKraneShares Emerging Markets Healthcare Index ETFN/ARXDProShares UltraShort Health CareN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBISProShares UltraShort Nasdaq BiotechnologyN/A170,000N/AOptionableHYLGGlobal X Health Care Covered Call & Growth ETFN/A110,000N/ANot OptionableKMEDKraneShares Emerging Markets Healthcare Index ETFN/A100,000N/ANot OptionableRXDProShares UltraShort Health CareN/A190,430N/ANot OptionableRXD, KMED, BIS, and HYLG HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comMedia Sentiment Over TimeRXD, KMED, BIS, and HYLG Company DescriptionsProShares UltraShort Nasdaq Biotechnology NASDAQ:BIS$19.07 +0.55 (+2.95%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.Global X Health Care Covered Call & Growth ETF NYSEARCA:HYLG$24.54 0.00 (0.00%) As of 02/21/2025The Global X Health Care Covered Call & Growth ETF (HYLG) is an exchange-traded fund that mostly invests in health care equity. FYLG tracks an index that holds S&P 500 financial stocks and sells one-month, at-the-money call options on up to 50% of each stock. HYLG was launched on Nov 21, 2022 and is managed by Global X.KraneShares Emerging Markets Healthcare Index ETF NYSEARCA:KMED$18.81 0.00 (0.00%) As of 04/17/2025The KraneShares Emerging Markets Healthcare Index ETF (KMED) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market-cap-weighted index of emerging market firms in the healthcare sector. KMED was launched on Aug 29, 2018 and is managed by KraneShares.ProShares UltraShort Health Care NYSEARCA:RXD$11.69 -0.10 (-0.85%) As of 04:10 PM EasternProShares UltraShort Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the inverse (opposite) of the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, to investments that, in combination, have economic characteristics that are inverse to those of the Index. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments. The Fund intends to concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. ProShare Advisors LLC serves as the investment advisor to the Fund. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Market Anticipation Builds: Joby Stock Climbs Ahead of Earnings Is Intuitive Surgical a Buy After Volatile Reaction to Earnings? Now Is the Time to Buy ServiceNow—The Rebound Is Real Archer Aviation Gets Analyst Target Upgrade: Time to Load Up? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
